These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30553517)

  • 1. Minireview: Addressing the retro-Michael instability of maleimide bioconjugates.
    Szijj PA; Bahou C; Chudasama V
    Drug Discov Today Technol; 2018 Dec; 30():27-34. PubMed ID: 30553517
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioconjugation with Maleimides: A Useful Tool for Chemical Biology.
    Ravasco JMJM; Faustino H; Trindade A; Gois PMP
    Chemistry; 2019 Jan; 25(1):43-59. PubMed ID: 30095185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stabilization of cysteine-linked antibody drug conjugates with N-aryl maleimides.
    Christie RJ; Fleming R; Bezabeh B; Woods R; Mao S; Harper J; Joseph A; Wang Q; Xu ZQ; Wu H; Gao C; Dimasi N
    J Control Release; 2015 Dec; 220(Pt B):660-70. PubMed ID: 26387744
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Covalent Modification of Biomolecules through Maleimide-Based Labeling Strategies.
    Renault K; Fredy JW; Renard PY; Sabot C
    Bioconjug Chem; 2018 Aug; 29(8):2497-2513. PubMed ID: 29954169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Understanding How the Stability of the Thiol-Maleimide Linkage Impacts the Pharmacokinetics of Lysine-Linked Antibody-Maytansinoid Conjugates.
    Ponte JF; Sun X; Yoder NC; Fishkin N; Laleau R; Coccia J; Lanieri L; Bogalhas M; Wang L; Wilhelm S; Widdison W; Pinkas J; Keating TA; Chari R; Erickson HK; Lambert JM
    Bioconjug Chem; 2016 Jul; 27(7):1588-98. PubMed ID: 27174129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tuning the Diels-Alder Reaction for Bioconjugation to Maleimide Drug-Linkers.
    St Amant AH; Lemen D; Florinas S; Mao S; Fazenbaker C; Zhong H; Wu H; Gao C; Christie RJ; Read de Alaniz J
    Bioconjug Chem; 2018 Jul; 29(7):2406-2414. PubMed ID: 29932647
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving the Stability of Maleimide-Thiol Conjugation for Drug Targeting.
    Lahnsteiner M; Kastner A; Mayr J; Roller A; Keppler BK; Kowol CR
    Chemistry; 2020 Dec; 26(68):15867-15870. PubMed ID: 32871016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single Mutation on Trastuzumab Modulates the Stability of Antibody-Drug Conjugates Built Using Acetal-Based Linkers and Thiol-Maleimide Chemistry.
    Ferhati X; Jiménez-Moreno E; Hoyt EA; Salluce G; Cabeza-Cabrerizo M; Navo CD; Compañón I; Akkapeddi P; Matos MJ; Salaverri N; Garrido P; Martínez A; Laserna V; Murray TV; Jiménez-Osés G; Ravn P; Bernardes GJL; Corzana F
    J Am Chem Soc; 2022 Mar; 144(12):5284-5294. PubMed ID: 35293206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Next-Generation Maleimides (NGMs) to Site-Selective Antibody Conjugation.
    Morais M; Forte N; Chudasama V; Baker JR
    Methods Mol Biol; 2019; 2033():15-24. PubMed ID: 31332744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-hydrolyzing maleimides improve the stability and pharmacological properties of antibody-drug conjugates.
    Lyon RP; Setter JR; Bovee TD; Doronina SO; Hunter JH; Anderson ME; Balasubramanian CL; Duniho SM; Leiske CI; Li F; Senter PD
    Nat Biotechnol; 2014 Oct; 32(10):1059-62. PubMed ID: 25194818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Ring-Opening Reaction of Succinimide Linkers in ADCs.
    Zheng K; Chen Y; Wang J; Zheng L; Hutchinson M; Persson J; Ji J
    J Pharm Sci; 2019 Jan; 108(1):133-141. PubMed ID: 30458165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protocols for lysine conjugation.
    Brun MP; Gauzy-Lazo L
    Methods Mol Biol; 2013; 1045():173-87. PubMed ID: 23913147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of Protein Bioconjugates via Cysteine-maleimide Chemistry.
    Mason AF; Thordarson P
    J Vis Exp; 2016 Jul; (113):. PubMed ID: 27501061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A Reactive Antibody Platform for One-Step Production of Antibody-Drug Conjugates through a Diels-Alder Reaction with Maleimide.
    St Amant AH; Huang F; Lin J; Lemen D; Chakiath C; Mao S; Fazenbaker C; Zhong H; Harper J; Xu W; Patel N; Adams L; Vijayakrishnan B; Howard PW; Marelli M; Wu H; Gao C; Read de Alaniz J; Christie RJ
    Bioconjug Chem; 2019 Sep; 30(9):2340-2348. PubMed ID: 31380623
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuning the Hydrolytic Stability of Next Generation Maleimide Cross-Linkers Enables Access to Albumin-Antibody Fragment Conjugates and tri-scFvs.
    Forte N; Livanos M; Miranda E; Morais M; Yang X; Rajkumar VS; Chester KA; Chudasama V; Baker JR
    Bioconjug Chem; 2018 Feb; 29(2):486-492. PubMed ID: 29384367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synthesis and Bioconjugation of Thiol-Reactive Reagents for the Creation of Site-Selectively Modified Immunoconjugates.
    Davydova M; Dewaele Le Roi G; Adumeau P; Zeglis BM
    J Vis Exp; 2019 Mar; (145):. PubMed ID: 30907883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of low recovery in the free drug assay for antibody drug conjugates by size exclusion-reversed phase two dimensional-liquid chromatography.
    Li Y; Stella C; Zheng L; Bechtel C; Gruenhagen J; Jacobson F; Medley CD
    J Chromatogr B Analyt Technol Biomed Life Sci; 2016 Oct; 1032():112-118. PubMed ID: 27212187
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of applicable thiol-linked antibody-drug conjugates with improved stability and therapeutic index.
    Wang Y; Xie F; Liu L; Xu X; Fan S; Zhong W; Zhou X
    Drug Deliv; 2022 Dec; 29(1):754-766. PubMed ID: 35244495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient and irreversible antibody-cysteine bioconjugation using carbonylacrylic reagents.
    Bernardim B; Matos MJ; Ferhati X; Compañón I; Guerreiro A; Akkapeddi P; Burtoloso ACB; Jiménez-Osés G; Corzana F; Bernardes GJL
    Nat Protoc; 2019 Jan; 14(1):86-99. PubMed ID: 30470819
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineered cysteine antibodies: an improved antibody-drug conjugate platform with a novel mechanism of drug-linker stability.
    Sussman D; Westendorf L; Meyer DW; Leiske CI; Anderson M; Okeley NM; Alley SC; Lyon R; Sanderson RJ; Carter PJ; Benjamin DR
    Protein Eng Des Sel; 2018 Feb; 31(2):47-54. PubMed ID: 29370435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.